Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on May 7, 2025

Rio Moving Launches 'Jane' – An AI Phone Assistant Trained on Over 30,000 Customer Calls
Rio Moving Launches “Jane” – An AI Phone Assistant Trained on Over 30,000 Customer Calls WY, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Revolutionizing Customer Service, One Call at a Time Rio Moving, a leading name in professional moving …

MontyCloud and Pax8 Partner to Simplify the Cloud for SMB-focused MSPs
Pax8 MSPs Can Now Access MontyCloud’s No-Code, AI-Driven CloudOps Platform to Operate Efficiently, Optimize Costs, and Monetize Cloud Services at Scale REDMOND, WA, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- MontyCloud Inc., a leading no-code …

APMG Proud to be Part of 5CS Joint Venture – A Gamechanger for Business Case Development
Transforming business case development with a smart, collaborative, online solution built on the proven Five Case Model. LONDON, HIGH WYCOMBE, UNITED KINGDOM, May 7, 2025 /EINPresswire.com/ -- APMG is delighted to announce the launch of 5CS (Five Case …

InnoCSR and Rango Engineering Solutions Sign Distribution Agreement to Accelerate Adoption of Good Bricks in Nepal
KATHMANDU, NEPAL, May 7, 2025 /EINPresswire.com/ -- InnoCSR has signed a landmark distribution agreement with Rango Engineering Solutions to accelerate the adoption of sustainable construction practices in Nepal’s Bagmati Province (Province 3). As part …

Retail Media IQ Announces Pre-Seed Raise and Launch of Global Ai-Enhanced Retail Media Platform
Company Raises $200k and Is One of Few Focused Exclusively on the Rapidly Growing Retail Ad Sector, Which Now Accounts for One in Four CPG Ad Dollars LOS ANGELES, CA, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- If success is “partly a function of …

From Beans to Belonging: A Fresh Take on the Humans in Digital Spaces
Dive into a quirky, whimsical digital oasis for misfits, trendsetters and influencers. LOS ANGELES, CA, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Bean$ and Things is a captivating memoir that takes readers on a thrilling journey through the wild …

WF Holding Limited Announces Underwriters’ Exercise of Over-Allotment Option
KUALA LUMPUR, May 07, 2025 (GLOBE NEWSWIRE) -- WF Holding Limited (NASDAQ: WFF) (“WF Holding” or “Company”), a Malaysia-based manufacturer of fiberglass reinforced plastic (FRP) products, today announced the underwriters of its initial public offering (the …

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …

Ayushman Infertility Center Makes Booking Appointments Easy Online
DELHI, NEW DELHI, INDIA, May 7, 2025 /EINPresswire.com/ -- Ayushman Infertility Center, a caring clinic in Delhi that helps people have babies, is happy to announce a new, simple way to book appointments online. This new system will make it easier for …

Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel
TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating its proprietary private blockchain technology, Grid Ledger System (“GLS”), today announced that it received a staff …

WANG & LEE GROUP, Inc. Bid Price Deficiency
HONG KONG, May 07, 2025 (GLOBE NEWSWIRE) -- WANG …

Oncocyte to Release First Quarter 2025 Results on May 12, 2025
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …

Brisbane Based Ian Lazar Digital Commence Features On Latest Medical and Dental Devices
Leading Sydney Lifestyle Magazine Ian Lazar Digital confirmed commencing featured posts focusing the work of Australian medical and Dental supply companies. BRISBANE, QLD, AUSTRALIA, May 7, 2025 /EINPresswire.com/ -- Ian Lazar Digital is an online …

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance
ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announced mid …

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …

Century Aluminum Company Reports First Quarter 2025 Results
CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data) Q1 2025 Q4 2024 Aluminum shipments ( …

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress
Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio …